AMBUJACEM

Revenue: The company's revenue for the quarter-ending June 2025 stood at Rs 10,289.07 Crore, up from Rs 8,311.48 Crore in June 2024. Net Profit: The net profit for the quarter-ending June 2025 was Rs 965.50 Crore, compared to Rs 786.24 Crore in June 2024. EPS: Earnings per share for the quarter-ending June 2025 was Rs 3.20, higher than Rs 2.67 in June ***** company's sales increased by approximately 5.68 percent in March 2025 compared to March ***** sales for the quarter ending June 2025 increased by approximately 23.79 percent compared to the quarter ending June 2024. Dividends: On April 29, 2025, a final dividend of Rs 2.00 per share (100%) was announced, effective from June 13, 2025.